Canid
United States
- New York, NY
- 22/09/2023
- Unknown
- $1,500,000
Every kid should be vaccinated. Today, we're making it harder and harder for people to fulfill that mission. From the pediatrician, to the parent, to the payer, the layers of confusing, expensive and tedious work involved in vaccinating children is hindering our ability to succeed in one of the most important public health initiatives of the century.
With the COVID vaccine for children rolling out, we're about to throw an additional wrench at everyone involved.
That's why we created Canid, where we worry about all of the nitty gritty details of executing a vaccine program from financing, to technology, to inventory, etc. so pediatricians can instead focus on the children.
- Industry Hospital & Health Care
- Website https://www.canid.io/
- LinkedIn https://www.linkedin.com/company/canid/about/
Related People
Pedro Sanchez de LozadaFounder
United States -
New York, New York
CEO @ Canid. Before: Early stage startup builder focused on Ops & Marketing at high-growth venture-backed companies: Merlin, Rinse, Udemy & more.
ErVimmune | $19,917,795 | (Jan 21, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
POINT.LAZ | $3,000,000 | (Jan 21, 2026)
Jetson(CANADA) | $50,000,000 | (Jan 21, 2026)
BrightInsight | $13,000,000 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)
Ultra Pouches | $11,000,000 | (Jan 21, 2026)
XBuild | $19,000,000 | (Jan 21, 2026)
Dam Secure | $4,000,000 | (Jan 21, 2026)
Infinitopes | $15,400,000 | (Jan 21, 2026)
Cosmos | $15,000,000 | (Jan 21, 2026)